These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32753129)

  • 21. Mortality Risk Following Application of a Paclitaxel-Coated Stent in Femoropopliteal Lesions.
    Katsuki T; Takahara M; Soga Y; Okamoto S; Iida O; Fujihara M; Kawasaki D; Ando K
    J Endovasc Ther; 2019 Oct; 26(5):593-599. PubMed ID: 31431154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
    Mehrotra S; Paramasivam G; Mishra S
    Curr Cardiol Rep; 2017 Feb; 19(2):10. PubMed ID: 28185166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
    Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
    J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.
    Ouriel K; Adelman MA; Rosenfield K; Scheinert D; Brodmann M; Peña C; Geraghty P; Lee A; White R; Clair DG
    JACC Cardiovasc Interv; 2019 Dec; 12(24):2515-2524. PubMed ID: 31575518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
    Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality After Paclitaxel-Coated Device Use in Dialysis Access: A Systematic Review and Meta-Analysis.
    Dinh K; Limmer AM; Paravastu SCV; Thomas SD; Bennett MH; Holden A; Varcoe RL
    J Endovasc Ther; 2019 Oct; 26(5):600-612. PubMed ID: 31455140
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.
    Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral Vascular Restenosis: A Retrospective Study on the Use of Drug-Eluting Balloons in Native Arteries, Vein Grafts and Dialysis Accesses.
    Björkman P; Peltola E; Albäck A; Venermo M
    Scand J Surg; 2017 Jun; 106(2):158-164. PubMed ID: 27270469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
    Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
    Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel-Coated Balloons and Eluting Stents: Is There a Mortality Risk in Patients With Peripheral Artery Disease?
    Beckman JA; White CJ
    Circulation; 2019 Oct; 140(16):1342-1351. PubMed ID: 31177820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does below-the-knee placement of drug-eluting stents improve clinical outcomes?
    Katsanos K; Spiliopoulos S; Krokidis M; Karnabatidis D; Siablis D
    J Cardiovasc Surg (Torino); 2012 Apr; 53(2):195-203. PubMed ID: 22456642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interventional angiology : Endovascular treatment of chronic and acute limb ischemia].
    Steiner S; Schmidt A; Scheinert D
    Internist (Berl); 2019 Feb; 60(2):149-160. PubMed ID: 30683968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes: Drug-eluting balloons for the treatment of critical limb ischaemia.
    Cully M
    Nat Rev Cardiol; 2013 Aug; 10(8):430. PubMed ID: 23836282
    [No Abstract]   [Full Text] [Related]  

  • 34. Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2015; 15(20):1-62. PubMed ID: 26719778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug coated balloon angioplasty in the treatment of peripheral artery disease.
    Colleran R; Harada Y; Cassese S; Byrne RA
    Expert Rev Med Devices; 2016 Jun; 13(6):569-82. PubMed ID: 27152654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-coated balloons for infrapopliteal disease: digging deep to understand the impact of a negative trial.
    Laird JR; Armstrong EJ
    J Am Coll Cardiol; 2014 Oct; 64(15):1577-9. PubMed ID: 25301460
    [No Abstract]   [Full Text] [Related]  

  • 37. Paclitaxel-Coated Peripheral Arterial Devices are Associated with Reduced Mortality in Younger Patients.
    Kumins NH; King AH; Ambani RN; Thomas JP; Bose S; Wong VL; Harth KC; Cho JS; Colvard B; Kashyap VS
    Ann Vasc Surg; 2021 Jan; 70():70-78. PubMed ID: 32795647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-eluting stents are associated with improved outcomes for the treatment of infrainguinal bypass graft stenoses.
    Hicks CW; Canner JK; Lum YW; Perler BA; Black JH; Abularrage CJ
    J Vasc Surg; 2019 Mar; 69(3):875-882. PubMed ID: 30497859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.
    Gandini R; Del Giudice C; Da Ros V; Sallustio F; Altobelli S; D'Onofrio A; Abrignani S; Vasili E; Stanzione P; Simonetti G
    J Endovasc Ther; 2014 Oct; 21(5):671-7. PubMed ID: 25290795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials.
    Cassese S; Byrne RA; Ott I; Ndrepepa G; Nerad M; Kastrati A; Fusaro M
    Circ Cardiovasc Interv; 2012 Aug; 5(4):582-9. PubMed ID: 22851526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.